Hwang JJ - Search Results

1

Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.

Stein MK, Williard FW, Xiu J, Tsao MW, Martin MG, Deschner BW, Dickson PV, Glazer ES, Yakoub D, Shibata D, Grothey AF, Philip PA, Hwang JJ, Shields AF, Marshall JL, Korn WM, Lenz HJ, Deneve JL. Stein MK, et al. Among authors: hwang jj. J Surg Oncol. 2020 Jun;121(8):1320-1328. doi: 10.1002/jso.25899. Epub 2020 Mar 12. J Surg Oncol. 2020. PMID: 32166754 Free PMC article.

2

Capecitabine: fulfilling the promise of oral chemotherapy.

Hwang JJ, Marshall JL. Hwang JJ, et al. Expert Opin Pharmacother. 2002 Jun;3(6):733-43. doi: 10.1517/14656566.3.6.733. Expert Opin Pharmacother. 2002. PMID: 12036413 Review.

3

Combined inhibition of topoisomerases: a phase I. Study of irinotecan and epirubicin.

Hwang JJ, Marshall JL, Rizvi N. Hwang JJ, et al. Oncology (Williston Park). 2003 May;17(5 Suppl 5):46-51. Oncology (Williston Park). 2003. PMID: 12800607 Review.

4

Improving the toxicity of irinotecan/5-FU/leucovorin: a 21-day schedule.

Hwang JJ, Eisenberg SG, Marshall JL. Hwang JJ, et al. Oncology (Williston Park). 2003 Sep;17(9 Suppl 8):37-43. Oncology (Williston Park). 2003. PMID: 14569847 Review.

5

Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma.

Hwang JJ, Kuruvilla J, Mendelson D, Pishvaian MJ, Deeken JF, Siu LL, Berger MS, Viallet J, Marshall JL. Hwang JJ, et al. Clin Cancer Res. 2010 Aug 1;16(15):4038-45. doi: 10.1158/1078-0432.CCR-10-0822. Epub 2010 Jun 10. Clin Cancer Res. 2010. PMID: 20538761 Free PMC article. Clinical Trial.

6

Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study.

Weinberg BA, Wang H, Yang X, Wu CS, Pishvaian MJ, He AR, Marshall JL, Hwang JJ. Weinberg BA, et al. Among authors: hwang jj. Gastrointest Cancer Res. 2014 May;7(3-4):91-7. Gastrointest Cancer Res. 2014. PMID: 25276262 Free PMC article.

7

Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.

Wu Z, Gabrielson A, Hwang JJ, Pishvaian MJ, Weiner LM, Zhuang T, Ley L, Marshall JL, He AR. Wu Z, et al. Among authors: hwang jj. Cancer Chemother Pharmacol. 2015 Dec;76(6):1309-14. doi: 10.1007/s00280-015-2855-z. Epub 2015 Oct 27. Cancer Chemother Pharmacol. 2015. PMID: 26507197 Clinical Trial.

8

Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.

Tian X, Shivapurkar N, Wu Z, Hwang JJ, Pishvaian MJ, Weiner LM, Ley L, Zhou D, Zhi X, Wellstein A, Marshall JL, He AR. Tian X, et al. Among authors: hwang jj. Oncol Lett. 2016 Mar;11(3):1645-1650. doi: 10.3892/ol.2016.4101. Epub 2016 Jan 13. Oncol Lett. 2016. PMID: 26998056 Free PMC article.

9

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer.

Al-Hajeili M, Shields AF, Hwang JJ, Wadlow RC, Marshall JL. Al-Hajeili M, et al. Among authors: hwang jj. Oncology (Williston Park). 2017 Apr 15;31(4):301-12. Oncology (Williston Park). 2017. PMID: 28412781 Free article. Review.

10

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.

Salem ME, Weinberg BA, Xiu J, El-Deiry WS, Hwang JJ, Gatalica Z, Philip PA, Shields AF, Lenz HJ, Marshall JL. Salem ME, et al. Among authors: hwang jj. Oncotarget. 2017 Sep 21;8(49):86356-86368. doi: 10.18632/oncotarget.21169. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156800 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,017 results

Search Page

Filters